Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy: A systematic review and meta-analysis

Toshihiro Nishizawa, Yuko Nishizawa, Naohisa Yahagi, Takanori Kanai, Masahiko Takahashi, Hidekazu Suzuki

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background and Aim: Several studies have reported that the application of rebamipide during the eradication of Helicobacter pylori can improve the eradication rate. However, the efficacy and safety are controversial. The present study systematically evaluated whether rebamipide improves the eradication rate of H.pylori by conducting a meta-analysis based on randomized controlled trials (RCTs). Methods: Literature searches were conducted in the following database: PubMed, the Cochrane Library, and the Igaku-chuo-zasshi database in Japan. A meta-analysis of all RCTs comparing rebamipide supplementation with non-rebamipide-containing therapy was performed. Results: We identified six randomized trials (611 patients). Pooled H.pylori eradication rates by per-protocol analysis were 73.3% and 61.4% for patients with or without rebamipide, respectively. The odds ratio was 1.74 (95% confidence interval. 1.19-2.53). Conclusions: Supplementation with rebamipide might be effective in increasing the H.pylori eradication rates of proton-pump inhibitor-amoxicillin dual therapy.

Original languageEnglish
Pages (from-to)20-24
Number of pages5
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume29
Issue numberS4
DOIs
Publication statusPublished - 2014 Dec 1

Fingerprint

Helicobacter pylori
Meta-Analysis
Pylorus
Randomized Controlled Trials
Databases
Therapeutics
Proton Pump Inhibitors
Amoxicillin
PubMed
Libraries
Japan
Odds Ratio
rebamipide
Confidence Intervals
Safety

Keywords

  • Eradication
  • Helicobacter pylori
  • Rebamipide

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy : A systematic review and meta-analysis. / Nishizawa, Toshihiro; Nishizawa, Yuko; Yahagi, Naohisa; Kanai, Takanori; Takahashi, Masahiko; Suzuki, Hidekazu.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 29, No. S4, 01.12.2014, p. 20-24.

Research output: Contribution to journalArticle

@article{1663e903e0644d6d82e52892e3deacd3,
title = "Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy: A systematic review and meta-analysis",
abstract = "Background and Aim: Several studies have reported that the application of rebamipide during the eradication of Helicobacter pylori can improve the eradication rate. However, the efficacy and safety are controversial. The present study systematically evaluated whether rebamipide improves the eradication rate of H.pylori by conducting a meta-analysis based on randomized controlled trials (RCTs). Methods: Literature searches were conducted in the following database: PubMed, the Cochrane Library, and the Igaku-chuo-zasshi database in Japan. A meta-analysis of all RCTs comparing rebamipide supplementation with non-rebamipide-containing therapy was performed. Results: We identified six randomized trials (611 patients). Pooled H.pylori eradication rates by per-protocol analysis were 73.3{\%} and 61.4{\%} for patients with or without rebamipide, respectively. The odds ratio was 1.74 (95{\%} confidence interval. 1.19-2.53). Conclusions: Supplementation with rebamipide might be effective in increasing the H.pylori eradication rates of proton-pump inhibitor-amoxicillin dual therapy.",
keywords = "Eradication, Helicobacter pylori, Rebamipide",
author = "Toshihiro Nishizawa and Yuko Nishizawa and Naohisa Yahagi and Takanori Kanai and Masahiko Takahashi and Hidekazu Suzuki",
year = "2014",
month = "12",
day = "1",
doi = "10.1111/jgh.12769",
language = "English",
volume = "29",
pages = "20--24",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "S4",

}

TY - JOUR

T1 - Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy

T2 - A systematic review and meta-analysis

AU - Nishizawa, Toshihiro

AU - Nishizawa, Yuko

AU - Yahagi, Naohisa

AU - Kanai, Takanori

AU - Takahashi, Masahiko

AU - Suzuki, Hidekazu

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Background and Aim: Several studies have reported that the application of rebamipide during the eradication of Helicobacter pylori can improve the eradication rate. However, the efficacy and safety are controversial. The present study systematically evaluated whether rebamipide improves the eradication rate of H.pylori by conducting a meta-analysis based on randomized controlled trials (RCTs). Methods: Literature searches were conducted in the following database: PubMed, the Cochrane Library, and the Igaku-chuo-zasshi database in Japan. A meta-analysis of all RCTs comparing rebamipide supplementation with non-rebamipide-containing therapy was performed. Results: We identified six randomized trials (611 patients). Pooled H.pylori eradication rates by per-protocol analysis were 73.3% and 61.4% for patients with or without rebamipide, respectively. The odds ratio was 1.74 (95% confidence interval. 1.19-2.53). Conclusions: Supplementation with rebamipide might be effective in increasing the H.pylori eradication rates of proton-pump inhibitor-amoxicillin dual therapy.

AB - Background and Aim: Several studies have reported that the application of rebamipide during the eradication of Helicobacter pylori can improve the eradication rate. However, the efficacy and safety are controversial. The present study systematically evaluated whether rebamipide improves the eradication rate of H.pylori by conducting a meta-analysis based on randomized controlled trials (RCTs). Methods: Literature searches were conducted in the following database: PubMed, the Cochrane Library, and the Igaku-chuo-zasshi database in Japan. A meta-analysis of all RCTs comparing rebamipide supplementation with non-rebamipide-containing therapy was performed. Results: We identified six randomized trials (611 patients). Pooled H.pylori eradication rates by per-protocol analysis were 73.3% and 61.4% for patients with or without rebamipide, respectively. The odds ratio was 1.74 (95% confidence interval. 1.19-2.53). Conclusions: Supplementation with rebamipide might be effective in increasing the H.pylori eradication rates of proton-pump inhibitor-amoxicillin dual therapy.

KW - Eradication

KW - Helicobacter pylori

KW - Rebamipide

UR - http://www.scopus.com/inward/record.url?scp=84919452476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919452476&partnerID=8YFLogxK

U2 - 10.1111/jgh.12769

DO - 10.1111/jgh.12769

M3 - Article

C2 - 25521728

AN - SCOPUS:84919452476

VL - 29

SP - 20

EP - 24

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - S4

ER -